Newsroom
Inflammatix in the news
Inflammatix Aims for 2024 Launch of 30-Minute Sepsis and Acute Infection Test
November 28, 2023
Your medical devices are getting smarter. Can the FDA keep them safe?
October 9, 2023
Point-of-care testing for infectious diseases in emergency settings
January 18, 2023
Do Your Genes Know What’s Making You Sick?
January 6, 2022
Artificial Intelligence for Clinical Decision Support in Sepsis
May 13, 2021
Inflammatix Checks off All the Right Boxes with Investors
March 19, 2021
Inflammatix nets $102M to advance its immune system tests for infectious diseases
March 16, 2021
Infection-detection system from Peninsula company scores $102M, aims to hit market this year
March 16, 2021
A Bright Future Ahead for Novel Markers of Infection
December 15, 2020
Inflammatix Awarded $7.4M in Additional BARDA Funding for POC System, Acute Infection Test
October 29, 2020
Inflammatix Moving Into Coronavirus Test Market With Gene Expression Host Response Platform
October 8, 2020
Machine Learning-Based Rapid Diagnostic Reads Immune System to Predict COVID-19 Severity Risk
September 30, 2020
Press releases
November 11, 2021
Inflammatix Awarded $1.7 Million Grant From National Institutes of Health (NIH)
March 16, 2021
Inflammatix Secures $102 Million in Series D Financing Led by D1 Capital Partners to Commercialize Novel Host Response Diagnostics
October 29, 2020
Inflammatix Announces $7.4 Million in Additional BARDA Funding to Advance ViraBac EZ Acute Infection Test
September 29, 2020
DARPA Awards Inflammatix up to $1.1 Million to Develop Diagnostic that Predicts COVID-19 Severity Risk
April 29, 2020
Study Demonstrates Substantial Cost Savings in Health Economic Model of the Inflammatix Host-Response Test for Sepsis
April 16, 2020
Inflammatix Appoints João Fonseca, Ph.D., as Chief Technology Officer
March 18, 2020
Leading Stanford Alumni Scientists and Physicians Launch StartX Med COVID-19 Task Force
March 4, 2020
New Inflammatix Study in Nature Communications Outlines Breakthrough in Diagnosing Acute Infections by Reading the Immune System
Videos
Machine learning blogs
Podcasts
Determining the Cause and Severity of Sepsis with a Point-of-Care Test
December 2025
Diagnosing Infection with Ljubomir Buturovic from Inflammatix
December 2023
Precision medicine for sepsis, Tim Sweeney, Co-Founder and CEO, Inflammatix, Inc.
April 2022
Advances in Sepsis Diagnostics: the HostDx Sepsis Platform
May 2018